Skip to content

Efficacy and Safety of Individualized Pattern-Based Traditional Chinese Medicine for Abdominal Obesity: A Pragmatic Multicenter Randomized Controlled Trial

Efficacy and Safety of Individualized Pattern-Based Traditional Chinese Medicine for Abdominal Obesity: A Pragmatic Multicenter Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002133
Enrollment
Unknown
Registered
2025-11-08
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity

Interventions

Control Group (Acupuncture Only):lifestyle intervention and acupuncture-only therapy
Experimental Group (Combined External Therapies):Treatment of lifestyle intervention combined with acupuncture and complex external therapy

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Meet the diagnostic criteria for abdominal obesity.(2)Aged between 18 and 65 years, inclusive (both male and female patients are eligible).(3)Patients who have voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Patients with secondary obesity attributable to factors such as medications, surgery, or endocrine disorders.(2)Patients with severe hepatic or renal impairment, cachexia, a history of major cardiovascular or cerebrovascular events, or psychiatric disorders.(3)Women who are pregnant or lactating.(4)Use of medications known to significantly affect body weight or appetite (e.g., weight-loss drugs, corticosteroids, antidepressants, glucose-lowering agents) within the past 3 months; or individuals with active plans to quit smoking or alcohol abstinence.(5)Participation in other acupuncture therapies or clinical trials within the past 3 months.(6)Local skin lesions or ulcers at the proposed intervention sites, or known metal allergy.(7)Individuals deemed unable to comply with the treatment protocol or adhere to the trial requirements throughout the study period.

Design outcomes

Primary

MeasureTime frame
Waist Circumference;

Secondary

MeasureTime frame
Body Weight;Body Mass Index;Hip Circumference (HC);Waist-to-Hip Ratio (WHR);the impact of weight on quality of life,IWQOL-Lite;STOP-Bang questionnaire,STOP-BANG;patient health questionnaire-9,PHQ-9;Fasting Blood Glucose (FBG);Glycated Hemoglobin (HbA1c);Fasting Insulin;Lipid Profile;Uric Acid (UA);Body Fat Percentage (BFP);Visceral Adiposity Index (VAI);

Countries

China

Contacts

Public ContactHua Li

Dongfang Hospital Beijing University of Chinese Medicine

lihua19831983@sina.com+86 13810616624

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026